Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2R | P25116 | 15/20 | 0.63 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | STAT1 | P42224 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3793030 | 0.86 | F2R (0.66) | F2RNPC1MAPTSTAT1RAB9A | |
| SCHEMBL16579598 | 0.83 | F2R (0.81) | F2RNPC1MAPTSTAT1RAB9A | |
| SCHEMBL640569 | 0.82 | F2R (0.66) | F2RNPC1MAPTSTAT1RAB9A | |
| SCHEMBL485847 | 0.82 | F2R (0.69) | F2RNPC1MAPTSTAT1RAB9A | |
| SCHEMBL640992 | 0.80 | F2R (0.73) | F2RNPC1MAPTSTAT1RAB9A | |
| SCHEMBL643116 | 0.80 | F2R (0.66) | F2RNPC1MAPTSTAT1RAB9A | |
| SCHEMBL641688 | 0.79 | F2R (0.66) | F2RNPC1FKBP1AALDH1A1 | |
| SCHEMBL1581192 | 0.79 | F2R (0.77) | F2RNPC1MAPTSTAT1RAB9A | |
| SCHEMBL641244 | 0.79 | F2R (0.65) | F2RNPC1MAPTSTAT1RAB9A | |
| SCHEMBL3796710 | 0.79 | F2R (0.65) | F2RNPC1MAPTSTAT1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2411363-B1 | SUBSTITUTED PIPERIDINES AS PAR-1 ANTAGONISTS | BAYER IP GMBH (DE) | 2015-10-07 | — | — | EP | disclosed |
| EP-2411363-A1 | SUBSTITUTED PIPERIDINES AS PAR-1 ANTAGONISTS | Bayer Pharma AG (DE) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010108608-A1 | SUBSTITUTED PIPERIDINES AS PAR-1 ANTAGONISTS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-09-30 | — | — | WO | disclosed |